# Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells

> **NCT03865394** · PHASE1,PHASE2 · COMPLETED · sponsor: **Medical University of Warsaw** · enrollment: 46 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** Application of allogeneic ADSC stem cells in fibrin gel
- **PROCEDURE:** Standard care in diabetic foot ulcer

## Key facts

- **NCT ID:** NCT03865394
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2021-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03865394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03865394, "Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03865394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*